BioClinica
Global clinical trial solutions. Real-world results.
- Solutions
- Science Library
- Support
- Partners
- About Us
BioClinica ensures that our protocols and technologies meet the highest standards for quality and innovation. Our Scientific Advisory Board is comprised of accomplished physicians with vast clinical and research experience who bring a breadth and depth of expertise to our mission. Their collective experience helps BioClinica provide unsurpassed image management expertise for clinical trials.
In an effort to improve the utilization of imaging in clinical trials, BioClinica is pleased to offer a new series of symposiums that focus on imaging in various therapeutic areas. Distinguished key opinion leaders and BioClinica scientific staff will educate Pharmaceutical and Biotech personnel about when and how to use imaging for optimal results. Lecture topics include clinical development, the blinded reading process, and response assessment criteria while spanning across multiple therapeutic areas, such as Oncology, Neurology, Musculoskeletal and Cardiovascular drug development.
Our complimentary symposiums are tailored to fit your company’s need. They can be offered at your facility or can be hosted by BioClinica. Alternatively, an off-site location of your choosing may provide the perfect setting to start team-building and provide education for a new protocol, or develop the team’s understanding of a disease state, its endpoints, and the challenges of imaging.
Oncology continues to be one of the leading areas of drug development focus in the pharmaceutical industry. BioClinica's, "Medical Imaging in Oncology", will provide a comprehensive review of topics which include the measurement methodologies which will encompass the historic perspective. The evaluation of these measurement techniques will be presented along with how to consider these methodologies in protocol development. Discussion of the FDA guidelines with case examples will be provided. Participants will have the opportunity to expand their knowledge of the challenges of imaging as it pertains to oncology clinical trials.
If your trial has an imaging component then an Imaging Core Lab (ICL) is the essential key to a successful clinical trial as it serves as the logistical hub for medical imaging. The blueprint for an ICL often revolves around the imaging review charter, an FDA required document that entails the physical movement of imaging and read design.